Related Experiment Video
Updated: Jan 8, 2026
Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Travel-associated carbapenem-resistant organisms at a time of increasing geopolitical instability: a UK perspective
Scott J C Pallett1, Sara E Boyd2, Aakash Khanijau3
1Clinical Infection Department, Chelsea and Westminster Hospitals NHS Foundation Trust, London, UK; Centre of Defence Pathology, Royal Centre of Defence Medicine, Queen Elizabeth Hospital, Birmingham, UK.
Background:
Conflict and catastrophe compromise multi-national healthcare delivery and present risks for the spread of carbapenem-resistant organisms (CROs). The risk of and ability to detect travel-associated CROs in the UK remain unclear.
Methods:
A 10-question survey was sent to microbiology/infection prevention and control (IPC) practitioners of 108 UK acute NHS Trusts/Regions/Boards, exploring recent experience and IPC practices for travel-associated CROs and approaches to extended-spectrum antimicrobial testing. Additionally, major trauma network centres were invited to review detected carbapenemase-producing organism (CPO) molecular data from March 2022 to April 2024, comparing associated travel by the World Health Organization global region using one-way analysis of variance.
Results:
Seventy-three surveys were returned. IPC approaches were highly variable, with 19 of 73 (26.0%) centres requiring modification to national screening guidelines. Twenty-four of 73 (32.9%) centres reported CROs associated with recent travel to major conflict areas. Twelve major trauma network centres contributed to review of detected CPOs, finding 297 of 1290 (23.0%) individuals with travel to 52 different countries. In total, 227 of 297 (76.4%) were screening results; 279 of 297 (93.9%) were Enterobacterales. A total of 112 of 297 (37.7%) had travelled to Europe, where carbapenemase diversity was greater than elsewhere (P< 0.001).
Interpretation:
A considerable range of UK centres are detecting CROs associated with travel to areas of current major conflict. A more didactic approach to travel history on the first contact with healthcare services is required to stratify CPO risk at admission. These data should be collected prospectively in parallel with projects which successfully embed taking an effective travel history to assess the risk of travel-associated infectious disease. This will allow clearer understanding of travel behaviours and trends, delineate risk and inform effective IPC.
Related Concept Videos
01:30Development of Antibiotic Resistance
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
01:17Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
01:25Urinary Tract Infection II: Pathophysiology
01:20Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...